-
Startseite
-
a-t-Archiv
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Geschenkabo
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
Volume 38, 12 January 2007 1/2007
 
  SPOT ON
 

Cardiotoxicity of cox-2-inhibitors and conventional NSAID: naproxen new standard

 
  REVIEW
 

Treatment of age-related macular degeneration (I)

 
  THERAPY FORM A CRITICAL VIEWPOINT
 

Once again: duration of therapy with clopidogrel (ISCOVER, PLAVIX) after drug-eluting stents

 
  IN BRIEF
 

Australia: price reduction for vaccine against human papilloma virus (HPV) GARDASIL
Olanzapine (ZYPREXA) and Eli Lilly: suppression of risk data

 
  CURRENT ADR NETWORK REPORT

Management of opiod-patches (e.g. Fentanyl (DUROGESIC)) fault-prone

 
  SIDE EFFECTS
 

US: market limitation of indications for telithromycine (KETEK) recommended

 
© arznei-telegramm 1/2007